a phase i clinical trial of ag-dnr on 11 patients bearing hepatocarcinoma revealed that despite a transitory hyperthermia ( 37-38 degrees c ) during the first day of the 4 day-perfusion , and modifications of hepatic enzymes in 3 cirrhotic patients , no hematologic and cardiac toxicity could be detected .
C2239176
hepatocarcinoma
C0015967
hyperthermia